J&J’s medtech unit sees positive Q1 but Cordis still lags
This article was originally published in Clinica
Johnson & Johnson’s medical device and diagnostics business witnessed a 13% increase in revenue in the first quarter of 2010 after being boosted by sales of surgical care products and orthopaedic devices.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals